RBB

7 September 2002

Excess Pricing in the Napp Chapter II Case – how much is too much?

RBB Brief 5 discusses the controversial issue of excess pricing as an abuse in the context of the UK Competition Act case involving Napp Pharmaceuticals

Downloadpdf (87 KB)

Our experience and expertise means our clients have the best chance of success before competition authorities and courts.

We have unrivalled experience across the full range of issues presented by competition law and related associated litigation.

Articles

All Articles
  • Brief #6810/09/2024
    Flight of fantasy? The European Commission’s Booking/Etraveli prohibition
  • Article03/09/2024
    RBB comments on proposed changes to competition test for mergers in Australia